ConductScience.org, home

Paper1600596

Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro.

Osann K and 2 others. Cancer Chemother Pharmacol, 1992. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro. Papers, record 1600596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1600596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1992
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.02
iCite
Revised in PubMed
2019-08-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Osann KK
2Sweet PP
3Slater LML M

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclosporineMajor topic
DaunorubicinMajor topic
Leukemia-Lymphoma, Adult T-CellMajor topic
VerapamilMajor topic
VincristineMajor topic
Drug Resistance
Drug Synergism
Humans
Kinetics
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1422420Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.Int J Radiat Oncol Biol Phys1979https://conductscience.org/library/papers/422420PubMed
22364376Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs.Cancer Res1990https://conductscience.org/library/papers/2364376PubMed
33457021Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.J Clin Invest1986https://conductscience.org/library/papers/3457021PubMed
41977512Verapamil and cyclosporin A potentiate the effects of chemotherapeutic drugs in the human medullary thyroid carcinoma TT cell line not expressing the 170 kDa P-glycoprotein.Cancer Lett1990https://conductscience.org/library/papers/1977512PubMed
56182160Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma.J Clin Invest1982https://conductscience.org/library/papers/6182160PubMed
61998966Correspondence re: Xiu F. Hu et al., Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res., 50: 2953-2957, 1990.Cancer Res1991https://conductscience.org/library/papers/1998966PubMed
72334897Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.Cancer Res1990https://conductscience.org/library/papers/2334897PubMed
87214365Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.Cancer Res1981https://conductscience.org/library/papers/7214365PubMed
92388483Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.Leukemia1990https://conductscience.org/library/papers/2388483PubMed
103455667Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3455667PubMed
11528263Terminology in the description of drug-radiation interactions.Int J Radiat Oncol Biol Phys1979https://conductscience.org/library/papers/528263PubMed
122390489Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.Br J Cancer1990https://conductscience.org/library/papers/2390489PubMed
132118896Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.Jpn J Cancer Res1990https://conductscience.org/library/papers/2118896PubMed
142032209Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanisms.Cancer Lett1991https://conductscience.org/library/papers/2032209PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
9657975Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.Biochem J1998https://conductscience.org/library/papers/9657975PubMed
9547669Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study.Invest New Drugs1997https://conductscience.org/library/papers/9547669PubMed
8281626
Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8281626PubMed
7987977Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/7987977PubMed
7765325Pharmacologic circumvention of multidrug resistance.Cytotechnology1993https://conductscience.org/library/papers/7765325PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1600596

GET https://conductscience.org/api/papers/v1/1600596/authors